225 related articles for article (PubMed ID: 6357436)
1. Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.
Arlin ZA
Cancer Treat Rep; 1983 Nov; 67(11):967-70. PubMed ID: 6357436
[No Abstract] [Full Text] [Related]
2. Treatment of acute leukemia with amsacrine and high-dose cytarabine.
Arlin ZA; Gaddipati J; Ahmed T; Mittelman A; Friedland M; Rieber E
Cancer Treat Rep; 1985 Sep; 69(9):1001-2. PubMed ID: 3839713
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
Miller LP; Miller DR; Tan CT
Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
[No Abstract] [Full Text] [Related]
4. Amsacrine in refractory acute leukemia.
Griffin JD; Maguire ME; Mayer RJ
Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
[TBL] [Abstract][Full Text] [Related]
5. Acute electrocardiographic changes induced by amsacrine.
Shinar E; Hasin Y
Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
[TBL] [Abstract][Full Text] [Related]
6. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
[No Abstract] [Full Text] [Related]
7. Combination amsacrine and high-dose cytosine arabinoside in acute leukemia.
Arlin ZA
J Clin Oncol; 1985 Jan; 3(1):128. PubMed ID: 3838101
[No Abstract] [Full Text] [Related]
8. Amsacrine with high-dose cytarabine in acute leukemia.
Zittoun R; Bury J; Stryckmans P; Lowenberg B; Peetermans M; Rozendaal KY; Haanen C; Kerkhofs M; Jehn U; Willemze R
Cancer Treat Rep; 1985 Dec; 69(12):1447-8. PubMed ID: 3841026
[No Abstract] [Full Text] [Related]
9. [Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].
Weil M; Auclerc MF; Schaison G; Auclerc G; Daubrisson A; Degos L; Caro J; Marty M; Jacquillat GI
Nouv Presse Med; 1982 Oct; 11(39):2911-4. PubMed ID: 6755389
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemia.
Letendre L; Hinemann V; Hoagland HC; Kovach JS
Med Pediatr Oncol; 1985; 13(4):232-4. PubMed ID: 3839284
[TBL] [Abstract][Full Text] [Related]
11. m-AMSA: phase II trial in advanced lymphoma and leukemia.
Case DC
Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
[TBL] [Abstract][Full Text] [Related]
12. Results of induction and consolidation treatment with intermediate and high-dose ara-C and m-AMSA containing regimens in patients with primarily failed or relapsed acute leukemia and non-Hodgkin's lymphoma.
Peters WG; Willemze R; Colly LP
Scand J Haematol Suppl; 1986; 44():7-16. PubMed ID: 3515513
[No Abstract] [Full Text] [Related]
13. Phase II study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia.
Abrams RA; Hanson G; Hansen RM; Anderson T
Cancer Treat Rep; 1986 Apr; 70(4):535. PubMed ID: 3754490
[No Abstract] [Full Text] [Related]
14. m-AMSA: a review of clinical data.
Zittoun R
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):649-53. PubMed ID: 3894030
[No Abstract] [Full Text] [Related]
15. Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
Arlin ZA; Sklaroff RB; Gee TS; Kempin SJ; Howard J; Clarkson BD; Young CW
Cancer Res; 1980 Sep; 40(9):3304-6. PubMed ID: 6933002
[TBL] [Abstract][Full Text] [Related]
16. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
[TBL] [Abstract][Full Text] [Related]
17. [Experiences with HD-Ara C treatment in leukemia patients].
Jehn U
Onkologie; 1985 Feb; 8(1):37-8. PubMed ID: 3885118
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
[No Abstract] [Full Text] [Related]
19. Amsacrine (AMSA)--a clinical review.
Louie AC; Issell BF
J Clin Oncol; 1985 Apr; 3(4):562-92. PubMed ID: 3884748
[No Abstract] [Full Text] [Related]
20. Trial of AMSA in acute leukemia.
Dupont JC; Garay GE; Scaghone C; Pavlovsky S; Woodley PV
Cancer Treat Rep; 1982 Jul; 66(7):1596-7. PubMed ID: 7046933
[No Abstract] [Full Text] [Related]
[Next] [New Search]